Patient engagement is in constant change and has evolved over the years into how care is delivered and how quality measures are developed, explained Marc Boutin, JD, chief executive officer
Patient engagement is in constant change and over the years it has evolved to focus on techniques or methods specific to a patient-centered approach in an effort to best encourage the patient to become more involved in their care, said Marc Boutin, JD, chief executive officer of the National Health Council.
Mr Boutin added that methods of delivering care and developing quality measures sit at the heart of the patient engagement approach now.
“At the end of the day, I think we’re going to bring patient engagement right into the heart of care and really transform how we deliver care,” Mr Boutin says.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More